To evaluate the effect of garlic tablet on metabolic syndrome in PCOS patients : A Randomized Double-blind Placebo-controlled Trial
- Conditions
- Metabolic syndrome in PCOS patients.
- Registration Number
- IRCT20150905023897N4
- Lead Sponsor
- Tarbiat modares University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 90
People are willing to participate in the study
fertility age between 15-49 years
Iranian women
no pregnancy
have at least literacy for read and write
no Mellitus Diabets according to primary FBS
no chronic and coagulation disorders
lack of consumption Anti lipids and Anti hypertensive and anti coagulative drugs
no consuming garlic in a daily diet more than one cubit
People with drug side effects.Individuals unwilling to continue to participate in the study failure to comply with treatment protocol
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evel of Triglyceride. Timepoint: First of study and 8 weeks after intervention. Method of measurement: blood biochemistry test.;Level of cholesterol. Timepoint: First of study and 8 weeks after intervention. Method of measurement: blood biochemistry test.;Blood level of HDL. Timepoint: First of study and 8 weeks after intervention. Method of measurement: blood biochemistry test.;Blood level of FBS. Timepoint: First of study and 8 weeks after intervention. Method of measurement: blood biochemistry test.;Level of systolic and diastolic blood pressure. Timepoint: First of study and 8 weeks after intervention. Method of measurement: Use of mercury barometer.;Waist to hip ratio. Timepoint: First of study and 8 weeks after intervention. Method of measurement: Use of meter.
- Secondary Outcome Measures
Name Time Method evel of CRP. Timepoint: First of study and 8 weeks after intervention. Method of measurement: Blood biochemistry test.;Menstrual dysfunction such as: Oligomenorrhea and amenorrhea. Timepoint: First of study and 8 weeks after intervention. Method of measurement: patient statements.;Clinical hyperandrogenemia. Timepoint: First of study and 8 weeks after intervention. Method of measurement: Blood biochemistry test and clinical symptom.;Ultrasound view of the ovaries. Timepoint: First of study and 8 weeks after intervention. Method of measurement: Use of ultrasound.;Sexual function. Timepoint: First of study and 8 weeks after intervention. Method of measurement: FSFI questionnaire.;Quality Of life. Timepoint: First of study and 8 weeks after intervention. Method of measurement: MPCOSQ questionnaire.